Low Density Lipoprotein Apheresis in Treatment of Hyperlipidemia: Experience with Four Different Technologies
- 1 June 2000
- journal article
- research article
- Published by Wiley in Therapeutic Apheresis
- Vol. 4 (3), 213-217
- https://doi.org/10.1046/j.1526-0968.2000.00180.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Low-density lipoprotein apheresis using the Liposorber system: features of the system and clinical benefits.Therapeutic Apheresis, 1998
- Short-Term and Long-Term Effects of Low-Density Lipoprotein (LDL) Apheresis on Restenosis after Percutaneous Transluminal Coronary Angioplasty (PTCA): Is Lowering Lp(a) by LDL Apheresis Effective on Restenosis after PTCA?Therapeutic Apheresis, 1998
- LDL Apheresis in Clinical Practice: Long-Term Treatment of Severe HyperlipidemiaTherapeutic Apheresis, 1997
- The Role of Low Density Lipoprotein Apheresis in the Treatment of Familial HypercholesterolemiaTherapeutic Apheresis, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- LDL apheresis using the liposorber® LA-15 system in coronary and peripheral vascular disease associated with severe hypercholesterolemiaCurrent Therapeutic Research, 1994
- The Helsinki Heart Study: coronary heart disease incidence during an extended follow‐upJournal of Internal Medicine, 1994
- Using the WHO (Rose) Angina Questionnaire in Cardiovascular EpidemiologyInternational Journal of Epidemiology, 1989
- Effect of intensive plasmapheresis on the plasma cholesterol concentration with familial hypercholesterolemiaAtherosclerosis, 1978